Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A2PHLF / Symbol: ISEE / Name: Iveric Bio / Stock / Biotechnology & Medical Research / Micro Cap /
Latest predictions
30.07.23
0.00%
22.07.23
0.00%
12.06.23
2.89%
04.06.23
2.25%
27.05.23
2.86%
€26.67
03.04.23
50.41%
buy
Best running prediction
€26.67
03.04.23
50.41%
buy
Your prediction

IVERIC bio Inc. Stock

Our community identified positive and negative aspects for IVERIC bio Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the IVERIC bio Inc. stock. On the other hand our users think that "Management" could be a problem in the future.

Pros and Cons of IVERIC bio Inc. in the next few years

Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of IVERIC bio Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
IVERIC bio Inc. - - - - - - -
Jaguar Health Inc. 22.310% 7.947% 53.774% 4.220% -46.026% -99.976% -
Vaxart Inc. 4.720% 5.492% 0.460% 73.382% 132.836% -76.461% -
aTyr Pharma Inc -0.570% -3.352% -4.420% -3.648% 34.109% -56.750% -72.479%

Comments

IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ISEE provided by MarketBeat
Show more

IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ISEE provided by MarketBeat
Show more

IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ISEE provided by MarketBeat
Show more